Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Denmark Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20113
20141
20152
20172
20183
20212
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Novo Nordisk A/S2
Aalborg University Hospital1
Alexion Pharmaceuticals, Inc.1
Arrowhead Pharmaceuticals1
Copenhagen University Hospital at Herlev1
Genzyme, a Sanofi Company1
Grifols Therapeutics LLC1
Pfizer1
Rigshospitalet, Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn19
Fragile X Syndrome4
Metabolic Diseases4
Metabolism, Inborn Errors4
Lipid Metabolism Disorders3
Pathologic Processes3
Blood Coagulation Disorders2
Brain Diseases2
Brain Diseases, Metabolic, Inborn2
Coagulation Protein Disorders2

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.